EA202090453A2 - ANTIBODIES TO CD40 - Google Patents
ANTIBODIES TO CD40Info
- Publication number
- EA202090453A2 EA202090453A2 EA202090453A EA202090453A EA202090453A2 EA 202090453 A2 EA202090453 A2 EA 202090453A2 EA 202090453 A EA202090453 A EA 202090453A EA 202090453 A EA202090453 A EA 202090453A EA 202090453 A2 EA202090453 A2 EA 202090453A2
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- antibodies
- fcriib
- antigen
- bind
- antibody
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Mycology (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
В изобретении предоставлены агонистические антитела или их антигенсвязывающие части, которые связываются с CD40 человека. Такие антитела необязательно содержат Fc-области с увеличенной специфичностью к FcRIIb. Изобретение также относится к способам лечения злокачественной опухоли или хронической инфекции посредством введения нуждающемуся в этом индивидууму антител по изобретению.The invention provides agonistic antibodies or antigen-binding parts thereof that bind to human CD40. Such antibodies optionally contain Fc regions with increased specificity for FcRIIb. The invention also relates to methods for treating a malignant tumor or a chronic infection by administering to a needy individual an antibody of the invention.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562252615P | 2015-11-09 | 2015-11-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
EA202090453A2 true EA202090453A2 (en) | 2020-06-30 |
EA202090453A3 EA202090453A3 (en) | 2020-09-30 |
Family
ID=71138781
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA202090453A EA202090453A3 (en) | 2015-11-09 | 2016-06-28 | ANTIBODIES TO CD40 |
Country Status (1)
Country | Link |
---|---|
EA (1) | EA202090453A3 (en) |
-
2016
- 2016-06-28 EA EA202090453A patent/EA202090453A3/en unknown
Also Published As
Publication number | Publication date |
---|---|
EA202090453A3 (en) | 2020-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201890162A1 (en) | ANTIBODIES TO CD40 WITH ENHANCED AGONISTIC ACTIVITY | |
EA201890175A1 (en) | ANTIBODIES TO CD40 | |
EA201890131A1 (en) | IMMUNOMODULATION AND TREATMENT OF SOLID TUMORS BY ANTIBODIES THAT SPECIFICALLY CONNECT CD38 | |
CY1124033T1 (en) | DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODIES | |
EA201891925A1 (en) | ANTIBODIES TO CD40 WITH STRENGTHENED AGONISTIC ACTIVITY | |
EA201892294A1 (en) | ANTIBODIES AND COMPOSITIONS AGAINST TIM-3 | |
EA201892362A1 (en) | AGONISTIC ANTIBODIES THAT ARE BINDING HUMAN CD40, AND THEIR OPTIONS | |
EA201990912A1 (en) | ANTI-LAG-3 ANTIBODIES AND THEIR COMPOSITIONS | |
EA201792589A1 (en) | ANTIBODIES AGAINST CD123 AND CONJUGATES OF INDICATED ANTIBODIES | |
EA201890305A1 (en) | HUMANIZED OR CHIMERIC CD3 ANTIBODIES | |
MX370818B (en) | Anti-b7-h1 antibodies for treating tumors. | |
EA201790288A1 (en) | ANTI-CTLA4 MONOCLONAL ANTIBODY OR ITS ANTIGEN-BINDING FRAGMENT, PHARMACEUTICAL COMPOSITION AND APPLICATION | |
EA201791208A1 (en) | Antibodies to CD38 for the treatment of acute myeloid leukemia | |
PH12017500493A1 (en) | Combination therapy | |
EA201791050A1 (en) | CONJUGATES OF ANTIBODIES AND MEDICINES | |
EA201690007A1 (en) | METALLIC ENZYME INHIBITING COMPOUNDS | |
EA201691541A1 (en) | NEW ANTI-BAFF ANTIBODIES | |
MX2018012493A (en) | Methods for monitoring and treating cancer. | |
NZ730186A (en) | Humanized anti-hepcidin antibodies and uses thereof | |
EA201891299A1 (en) | THERAPEUTIC ANTIBODIES TO CD9 | |
EA201992318A1 (en) | COMPOSITIONS AND METHODS FOR DIAGNOSTIC AND TREATMENT OF PROSTATE CANCER USING A MOLECULE BINDING PROGASTRIN | |
WO2018089807A3 (en) | Anti-cd46 antibodies and methods of use | |
EA201791970A1 (en) | METHOD FOR TREATING PRIMARY SCLEROSED HOLANGITIS | |
MX2019014090A (en) | Methods for the treatment of chronic pouchitis. | |
EA201792282A1 (en) | METHODS OF TREATMENT OF DISEASES |